These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9872000)

  • 1. Appearance of fosfomycin resistant Rahnella aquatilis clinically isolated in Japan.
    O'Hara K; Chen J; Shigenobu F; Nakamura A; Taniguchi K; Shimojima M; Ida H; Yoshikawa E; Tsuboi I; Mizuoka K; Sawai T
    Microbios; 1998; 95(381):109-15. PubMed ID: 9872000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.
    Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
    J Antimicrob Chemother; 2006 Oct; 58(4):848-52. PubMed ID: 16891630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-determined resistance to fosfomycin in Serratia marcescens.
    Mendoza C; Garcia JM; Llaneza J; Mendez FJ; Hardisson C; Ortiz JM
    Antimicrob Agents Chemother; 1980 Aug; 18(2):215-9. PubMed ID: 7004337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence and dispersion of plasmids conferring fosfomycin resistance in enterobacteria].
    Hardisson C; Villar CJ; Llaneza J; Mendoza MC
    Pathol Biol (Paris); 1984 Sep; 32(7):755-8. PubMed ID: 6387596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
    Garau J
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
    Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
    Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of quinolone-resistant Enterobacteriaceae uropathogens to fosfomycin trometamol, in Dakar, Senegal.
    Nabeth P; Perrier-Gros-Claude JD; Juergens-Behr A; Dromigny JA
    Scand J Infect Dis; 2005; 37(6-7):497-9. PubMed ID: 16012011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10.
    Pogue JM; Marchaim D; Abreu-Lanfranco O; Sunkara B; Mynatt RP; Zhao JJ; Bheemreddy S; Hayakawa K; Martin ET; Dhar S; Kaye KS; Lephart PR
    J Antibiot (Tokyo); 2013 Oct; 66(10):625-7. PubMed ID: 23715037
    [No Abstract]   [Full Text] [Related]  

  • 11. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
    Aykut Arca E; Karabiber N
    Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
    Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
    J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological cost associated with fosfomycin resistance in Escherichia coli isolates from urinary tract infections].
    Alós JI; García-Peña P; Tamayo J
    Rev Esp Quimioter; 2007 Jun; 20(2):211-5. PubMed ID: 17893758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial susceptibility of enterobacteriaceae isolated from raw horsemeat isolated for human consumption (basashi).
    Furuhata K; Ishizaki N; Fukuyama M
    Biocontrol Sci; 2015; 20(1):19-25. PubMed ID: 25817809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and antibiotic sensitivity of Enterobacteriaceae isolated from a group of Jordanian patients with community acquired urinary tract infections.
    Abu Shaqra Q
    Cytobios; 2000; 101(396):15-21. PubMed ID: 10697742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic-resistant Serratia marcescens infection in a hospital.
    Ambrosio RE; Van Wyk AJ; De Klerk HC
    S Afr Med J; 1979 Apr; 55(15):584-7. PubMed ID: 380020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Statistical observation of urinary tract infections by Serratia marcescens].
    Kamiryo Y; Sakatoku J
    Hinyokika Kiyo; 1983 Apr; 29(4):401-10. PubMed ID: 6203384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural antibiotic susceptibility of Rahnella aquatilis and R. aquatilis-related strains.
    Stock I; Grüger T; Wiedemann B
    J Chemother; 2000 Feb; 12(1):30-9. PubMed ID: 10768513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosfomycin and plasmidic resistance.
    Baquero F; López-Brea M; Valls A; Cañedo T
    Chemotherapy; 1977; 23 Suppl 1():133-40. PubMed ID: 318973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic susceptibility patterns surveillance and clinical distribution of Enterobacteriaceae.
    Garbagnoli P; Pagani L
    Microbiologica; 1992 Apr; 15(2):135-47. PubMed ID: 1602984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.